Proteases are critical enzymes in various cellular pathways, ensuring protein turnover, maturation, and function. The proteases associated with the ubiquitin-fold modifier (UFM) system, such as CCP2, play specific roles in the post-translational modification of target proteins. Given this context, activating these proteases can be a way to amplify or enhance the UFMylation system's effects. Chemical activators for CCP2, specifically, can be divided into direct and indirect modulators.
Direct activators would engage with CCP2, enhancing its proteolytic activity. While no such compounds have been explicitly identified for CCP2, cysteine protease, like Calpeptin, can stabilize or potentiate the function of related enzymes, suggesting al avenue for CCP2 activation. On the other hand, indirect activators work by modulating the cellular environment or related pathways to influence CCP2. Proteasome, such as Epoxomicin or MG-262, stabilize the proteolytic environment in the cell, benefiting UFM proteases like CCP2. In essence, the proposed activators span a broad spectrum of functionalities. Their selection is based on understanding the proteolytic environment and related pathways that can intersect with the UFM system. The effectiveness of these chemicals would depend on their concentrations, cellular contexts, and interplay with other cellular components.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK is a pan-caspase inhibitor. As caspases are cysteine proteases, there could be an indirect effect on UFM proteases by modulating the cellular protease environment. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin is a potent proteasome inhibitor. By inhibiting proteasomal degradation, it might stabilize UFM proteases and enhance their functional lifespan in the cell. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
MG-262 is another proteasome inhibitor. Similar to Epoxomicin, it can stabilize proteases in the UFM system by reducing their degradation. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin is a specific inhibitor of the proteasome, leading to accumulation of poly-ubiquitinated proteins. This environment might indirectly favor UFM protease activity. | ||||||